The breast cancer quality of care study (BQUAL): A multi-center study to determine causes for noncompliance with breast cancer adjuvant therapy

Breast Journal

Volumn 18, Issue 3, 2012, Pages 203-213

  Neugut, Alfred I ^a,b,c   Hillyer, Grace Clarke ^a   Kushi, Lawrence H ^d   Lamerato, Lois ^e   Nathanson, S David ^e   Ambrosone, Christine B ^f   Bovbjerg, Dana H ^g   Mandelblatt, Jeanne S ^h   Magai, Carol ⁱ   Tsai, Wei Yann ^c   Jacobson, Judith S ^b,c   Hershman, Dawn L ^a,b,c  

^a NewYork Presbyterian Hospital   (United States)

^b Columbia University ^*  (United States)

^c Kaiser Permanente of Northern California ^*  (United States)

^d DIVISION OF RESEARCH   (United States)

^e HENRY FORD HEALTH SYSTEM   (United States)

^f ROSWELL PARK CANCER INSTITUTE   (United States)

^g UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^h GEORGETOWN UNIVERSITY   (United States)

ⁱ LONG ISLAND UNIVERSITY   (United States)

Author keywords

adherence; adjuvant therapy; breast cancer; early discontinuation; persistence; quality of care; racial disparities

Indexed keywords

ANTINEOPLASTIC AGENT; DNA; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AFRICAN AMERICAN; AGED; ASIAN; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER MORTALITY; COLLEGE; DEMOGRAPHY; EDUCATIONAL STATUS; EMOTION; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; FEMALE; FOLLOW UP; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HISPANIC; HUMAN; INCOME; INTERVIEW; MAJOR CLINICAL STUDY; MARRIAGE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT SATISFACTION; PHARMACOGENOMICS; QUALITY OF LIFE; RACE DIFFERENCE; REVIEW; TUMOR DIFFERENTIATION;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; FEMALE; HUMANS; MIDDLE AGED; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; QUALITY ASSURANCE, HEALTH CARE; QUESTIONNAIRES; RECEPTORS, ESTROGEN; SOCIAL CLASS; TREATMENT OUTCOME;

EID: 84861183258     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2012.01240.x     Document Type: Review

References (52)

1. Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005; 366: 2087-106. (Pubitemid 41797643)
2. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005; 365: 1687-717.
3. Hershman D, McBride R, Jacobson JS, et al. Racial disparities in treatment and survival among women with early-stage breast cancer. J Clin Oncol 2005; 23: 6639-46. (Pubitemid 46190258)
4. Lyman GH, Dale DC, Crawford J,. Incidence and predictors of low dose-intensity in adjuvant breast cancer chemotherapy: a nationwide study of community practices. J Clin Oncol 2003; 21: 4524-31. (Pubitemid 46594022)
5. Partridge AH, Wang PS, Winer EP, Avorn J,. Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. J Clin Oncol 2003; 21: 602-6. (Pubitemid 46621892)
6. Bickell NA, McEvoy MD,. Physicians' reasons for failing to deliver effective breast cancer care: a framework for underuse. Med Care 2003; 41: 442-6.
7. Hershman DL, Wang X, McBride R, Jacobson JS, Grann VR, Neugut AI,. Delay of adjuvant chemotherapy initiation following breast cancer surgery among elderly women. Breast Cancer Res Treat 2006; 99: 313-21. (Pubitemid 44337924)
8. Hershman DL, Wang X, McBride R, Jacobson JS, Grann VR, Neugut AI,. Delay in initiating adjuvant radiotherapy following breast conservation surgery and its impact on survival. Int J Radiat Oncol Biol Phys 2006; 65: 1353-60. (Pubitemid 44425226)
9. Fedewa SA, Ward EM, Stewart AK, Edge SB,. Delays in adjuvant chemotherapy treatment among patients with breast cancer are more likely in African American and Hispanic populations: a national cohort study 2004-2006. J Clin Oncol 2010; 28: 4135-41.
10. Silliman RA, Guadagnoli E, Weitberg AB, Mor V,. Age as a predictor of diagnostic and initial treatment intensity in newly diagnosed breast cancer patients. J Gerontol 1989; 44: M46-50.
11. Li CI, Malone KE, Daling JR,. Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med 2003; 163: 49-56. (Pubitemid 36091600)
12. Hassett MJ, Griggs JJ,. Disparities in breast cancer adjuvant chemotherapy: moving beyond yes or no. J Clin Oncol 2009; 27: 2120-1.
13. Bickell NA, LePar F, Wang JJ, Leventhal H,. Lost opportunities: physicians' reasons and disparities in breast cancer treatment. J Clin Oncol 2007; 25: 2516-21. (Pubitemid 47041223)
14. Magai C, Consedine N, Neugut AI, Hershman DL,. Common psychosocial factors underlying breast cancer screening and breast cancer treatment adherence: a conceptual review and synthesis. J Womens Health (Larchmt) 2007; 16: 11-23.
15. Magai C, Consedine NS, Adjei BA, Hershman D, Neugut A,. Psychosocial influences on suboptimal adjuvant breast cancer treatment adherence among African American women: implications for education and intervention. Health Educ Behav 2008; 35: 835-54.
16. Osterberg L, Blaschke T,. Adherence to medication. N Engl J Med 2005; 353: 487-97. (Pubitemid 41127293)
17. Andrade SE, Kahler KH, Frech F, Chan KA,. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf 2006; 15: 565-74; discussion 75-7. (Pubitemid 44336271)
18. Cutler DM, Everett W,. Thinking outside the pillbox-medication adherence as a priority for health care reform. N Engl J Med 2010; 362: 1553-5.
19. Partridge AH, LaFountain A, Mayer E, Taylor BS, Winer E, Asnis-Alibozek A,. Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer. J Clin Oncol 2008; 26: 556-62. (Pubitemid 351264348)
20. Kimmick G, Anderson R, Camacho F, Bhosle M, Hwang W, Balkrishnan R,. Adjuvant hormonal therapy use among insured, low-income women with breast cancer. J Clin Oncol 2009; 27: 3445-51.
21. Ziller V, Kalder M, Albert US, et al. Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer. Ann Oncol 2009; 20: 431-6.
22. Chlebowski RT, Geller ML,. Adherence to endocrine therapy for breast cancer. Oncology 2006; 71: 1-9.
23. Lash TL, Fox MP, Westrup JL, Fink AK, Silliman RA,. Adherence to tamoxifen over the five-year course. Breast Cancer Res Treat 2006; 99: 215-20. (Pubitemid 44268270)
24. Noens L, van Lierde MA, De Bock R, et al. Prevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: the ADAGIO study. Blood 2009; 113: 5401-11.
25. Darkow T, Henk HJ, Thomas SK, et al. Treatment interruptions and non-adherence with imatinib and associated healthcare costs: a retrospective analysis among managed care patients with chronic myelogenous leukaemia. Pharmacoeconomics 2007; 25: 481-96. (Pubitemid 46849189)
26. Escalada P, Griffiths P,. Do people with cancer comply with oral chemotherapy treatments? Br J Community Nurs 2006; 11: 532-6.
27. Fink AK, Gurwitz J, Rakowski W, Guadagnoli E, Silliman RA,. Patient beliefs and tamoxifen discontinuance in older women with estrogen receptor-positive breast cancer. J Clin Oncol 2004; 22: 3309-15. (Pubitemid 41103687)
28. Grunfeld EA, Hunter MS, Sikka P, Mittal S,. Adherence beliefs among breast cancer patients taking tamoxifen. Patient Educ Couns 2005; 59: 97-102. (Pubitemid 41399883)
29. Kwan ML, Ambrosone CB, Lee MM, et al. The Pathways Study: a prospective study of breast cancer survivorship within Kaiser Permanente Northern California. Cancer Causes Control 2008; 19: 1065-76.
30. Ambrosone CB, Ciupak GL, Bandera EV, et al. Conducting molecular epidemiological research in the age of HIPAA: a multi-institutional case-control study of breast cancer in African-American and European-American women. J Oncol 2009; 2009: 871250.
31. Mandelblatt J, Schechter CB, Lawrence W, Yi B, Cullen J,. The SPECTRUM population model of the impact of screening and treatment on U.S. breast cancer trends from 1975 to 2000: principles and practice of the model methods. J Natl Cancer Inst Monogr 2006; 36: 47-55.
32. Brady MJ, Cella DF, Mo F, et al. Reliability and validity of the functional assessment of cancer therapy-breast quality-of-life instrument. J Clin Oncol 1997; 15: 974-86. (Pubitemid 27106280)
33. Holmes-Rovner M, Kroll J, Schmitt N, et al. Patient satisfaction with health care decisions: the satisfaction with decision scale. Med Decis Making 1996; 16: 58-64. (Pubitemid 26017908)
34. O'Connor AM,. Effects of framing and level of probability on patients' preferences for cancer chemotherapy. J Clin Epidemiol 1989; 42: 119-26. (Pubitemid 19069802)
35. Atkinson MJ, Sinha A, Hass SL, et al. Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Health Qual Life Outcomes 2004; 2: 26.
36. Llewellyn-Thomas HA, McGreal MJ, Thiel EC, Fine S, Erlichman C,. Patients' willingness to enter clinical trials: measuring the association with perceived benefit and preference for decision participation. Soc Sci Med 1991; 32: 35-42.
37. Portenoy RK, Thaler HT, Kornblith AB, et al. The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer 1994; 30A: 1326-36. (Pubitemid 24322071)
38. Cella DF, Peterman A, Hudgens S, Webster K, Socinski MA,. Measuring the side effects of taxane therapy in oncology: The Functional Assessment of Cancer Therapy-Taxane (FACT-Taxane). Cancer 2003; 98: 822-31. (Pubitemid 36959280)
39. Stanton AL, Bernaards CA, Ganz PA,. The BCPT Symptom Scales: a measure of physical symptoms for women diagnosed with or at risk for breast cancer. J Natl Cancer Inst 2005; 97: 448-56. (Pubitemid 40528608)
40. Chew LD, Bradley KA, Boyko EJ,. Brief questions to identify patients with inadequate health literacy. Family Med 2004; 36: 588-94. (Pubitemid 39209565)
41. Miller MD, Ferris DG,. Measurement of subjective phenomena in primary care research: the Visual Analogue Scale. Family Pract Res J 1993; 13: 15-24.
42. Thompson HS, Valdimarsdottir HB, Winkel G, Jandorf L, Redd W,. The Group-Based Medical Mistrust Scale: psychometric properties and association with breast cancer screening. Prev Med 2004; 38: 209-18 [doi: DOI: ]. (Pubitemid 38050292)
43. Watson M, Greer S, Young J, Inayat Q, Burgess C, Robertson B,. Development of a questionnaire measure of adjustment to cancer: the MAC scale. Psychol Med 1988; 18: 203-9. (Pubitemid 18071647)
44. Tedeschi RG, Calhoun LG,. The post-traumatic growth inventory: measuring the positive legacy of trauma. J Trauma Stress 1996; 9: 455-71. (Pubitemid 126710047)
45. Lewis CA, Shevlin M, McGuckin C, Navrátil M,. The Santa Clara Strength of Religious Faith Questionnaire: confirmatory factor analysis. Pastoral Psychol 2001; 49: 379-84. (Pubitemid 33809819)
46. Plante TG, Boccaccini MT,. The Santa Clara Strength of Religious Faith Questionnaire. Pastoral Psychol 1997; 45: 375-87.
47. Scheier MF, Carver CS, Bridges MW,. Distinguishing optimism from neuroticism (and trait anxiety, self-mastery, and self-esteem): a reevaluation of the Life Orientation Test. J Pers Soc Psychol 1994; 67: 1063-78.
48. Stanton AL, Danoff-Burg S, Cameron CL, et al. Emotionally expressive coping predicts psychological and physical adjustment to breast cancer. J Consult Clin Psychol 2000; 68: 875-82 [doi:].
49. Sherbourne CD, Stewart AL,. The MOS social support survey. Soc Sci Med 1991; 32: 705-14.
50. Stewart AL, Nápoles-Springer AM, Gregorich SE, Santoyo-Olsson J,. Interpersonal processes of care survey: patient-reported measures for diverse groups. Health Serv Res 2007; 42 (3p1): 1235-56. (Pubitemid 46699467)
51. Weiss DS, Marmar CR,. The impact of event scale-revised. In:, Wilson JP, Keane TM, eds. Assessing Psychological Trauma and PTSD. New York: Guilford Press, 1997: 399-411.
52. Bartholomew K, Horowitz LM,. Attachment styles among young adults: a test of a four-category model. J Pers Soc Psychol 1991; 61: 226-44.